Pharming (PHAR) Net Margin (2020 - 2026)
Pharming's (PHAR) quarterly Net Margin came in at 6.36% in Q2 2026, up 581782726.0% YoY from N/an in Q2 2025, and up 100.0% on a QoQ basis from 20550195315195.93% in Q1 2026.
Powered by 
Analysis
Pharming (PHAR) Net Margin (2020 - 2026) Analysis & Trends
Pharming (PHAR) has 7 years of Net Margin data on file, last reported at 6.36% in Q2 2026.
- Quarterly Net Margin rose 581782726.0% year-over-year to 6.36% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 10.9% (up 2060.0% YoY) and the FY2025 annual result came in at 0.76%, up 474.0% from the prior year.
- Net Margin rose to 6.36% in Q2 2026, from 20550195315195.93% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 31.34% in Q2 2022 to a low of 20550195315195.93% in Q1 2026.
- A 5-year average of 1208835360768.79% and a median of 7.19% in 2024 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 581782726 bps in 2026, down 2000000000 bps in 2026.
- Tracing PHAR's Net Margin over 5 years: stood at 18.74% in 2022, then slumped by 149 bps to 9.11% in 2023, then grew by 21 bps to 7.19% in 2024, then jumped by 100 bps to 0.0% in 2025, then sank by 127711451 bps to 6.36% in 2026.
- The last three Net Margin figures came in at 6.36% (Q2 2026), 20550195315195.93% (Q1 2026), and 0.0% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 12.09% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -3.12% |
| 10 | Pharming | 781.07 Mn | 621.57 Mn | 141.47 Mn | -2.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.20% |
| Mar 31, 2026 | -7.20% |
| Dec 31, 2025 | 5,048,826.29% |
| Sep 30, 2025 | -2.87% |
| Mar 31, 2025 | -18.61% |
| Dec 31, 2024 | -5.79% |
| Sep 30, 2024 | 15.26% |
| Jun 30, 2024 | -18,442,645.07% |
| Mar 31, 2024 | -22.39% |
| Dec 31, 2023 | -16.60% |
| Sep 30, 2023 | 4.73% |
| Jun 30, 2023 | -28.57% |
| Mar 31, 2023 | -48.90% |
| Dec 31, 2022 | 25.10% |
| Sep 30, 2022 | 17.53% |
| Jun 30, 2022 | 43.09% |
| Mar 31, 2022 | 11.59% |
| Dec 31, 2021 | 16.30% |
| Sep 30, 2021 | -33.83% |
| Jun 30, 2021 | 24.63% |